Gufic Biosciences · NSE: GUFICBIO · BSE: 509079
Q2 FY19 results · Jul–Sep 2018
Gufic Biosciences reported revenue from operations of ₹92.42 crore and net profit of ₹6.19 crore for Q2 FY19 (Jul–Sep 2018), on a standalone basis.
| Item | Q2 FY19 | Q2 FY18 | YoY | Q1 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 92.42 | — | — | 78.49 | +17.7% |
| Other income | 0.70 | — | — | 0.22 | +210.5% |
| Total income | 93.12 | — | — | 78.72 | +18.3% |
| Profit before tax | 9.52 | — | — | 6.52 | +45.9% |
| Net profit for the period | 6.19 | — | — | 3.93 | +57.4% |
| EPS, basic (₹) | 0.79 | — | — | 0.51 | +54.9% |
| Net margin (%) | 6.7 | — | 5.0 |
Standalone
- Filed with BSE
- 20 Nov 2018, 14:12 IST
- Board meeting
- 13 Nov 2018
- Period
- 01 Jul 2018 to 30 Sep 2018
- Review status
- Unaudited
- Source
- XBRL filing on BSE